Quadrant Capital Group LLC
- SEC CIK
- 0001650717
- Latest filing
- Aug 14, 2026
TBPH holding history
Theravance Biopharma, Inc. in every 13F filed by Quadrant Capital Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TBPH overviewAll 13F holders of TBPHFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 16
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −335−100.0% | Sold out | Holders |
| Q1 2025 | 335 | $2.99K | <0.1% | −697−67.5% | Reduced | Holders |
| Q4 2024 | 1,032 | $9.71K | <0.1% | +806+356.6% | Added | Holders |
| Q3 2024 | 226 | $1.82K | <0.1% | −763−77.1% | Reduced | Holders |
| Q2 2024 | 989 | $8.39K | <0.1% | +242+32.4% | Added | Holders |
| Q1 2024 | 747 | $6.70K | <0.1% | +461+161.2% | Added | Holders |
| Q4 2023 | 286 | $3.21K | <0.1% | +234+450.0% | Added | Holders |
| Q3 2023 | 52 | $449 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 52 | $539 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 52 | $565 | <0.1% | −76−59.4% | Reduced | Holders |
| Q4 2022 | 128 | $1.44K | <0.1% | −7−5.2% | Reduced | Holders |
| Q3 2022 | 135 | $1.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 135 | $1.00K | <0.1% | −39−22.4% | Reduced | Holders |
| Q1 2022 | 174 | $2.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 174 | $2.00K | <0.1% | +137+370.3% | Added | Holders |
| Q3 2021 | 37 | $0 | 0.0% | +12+48.0% | Added | Holders |
| Q2 2021 | 25 | $0 | 0.0% | +25 | New | Holders |